Pharma and Biotech Daily: Cutting through the noise in the world of healthcare.
MP3•Episode home
Manage episode 434988072 series 3478766
Content provided by Pharma and BioTech News and BioTech News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma and BioTech News and BioTech News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon are facing layoffs. A journal has retracted papers on MDMA-assisted therapy, and Evotec is cutting jobs and exiting gene therapy. Galderma has received FDA approval for a skin condition treatment, and trends in cell therapy research and market strategies of pharma giants are being explored. The impact of AI technology on clinical trials, patient-centric commercialization strategies, and upcoming events in the biopharma industry are also discussed.Texas is suing the Biden administration over a nursing home staffing mandate requiring at least 3.48 hours of care per resident each day. A report accuses HCA of driving away doctors and downgrading care at Mission Hospital after acquiring it. Medicare drug price cuts may have limited early impact but could have bigger future implications for drug research. Nurses may need their own AI documentation tools due to complex work and shifting tasks. Additionally, Medicaid has overtaken Medicare Advantage as a concern for health insurers in the second quarter. The text also includes information on updating healthcare sales approaches and using data to improve patient outcomes.Pfizer and BioNTech's COVID-flu shot candidate faced setbacks in Phase III trials, potentially giving Moderna an advantage with its superior vaccine. Medicare negotiated drug prices touted by the Biden-Harris administration are criticized as hollow victories. Other news includes Lycos slashing its workforce, Bavarian Nordic's potential windfall with an emergency vaccine, and AstraZeneca's Imfinzi scoring FDA approvals. Layoff announcements in the biopharma industry are also highlighted. The role of Quality Assurance and Regulatory Affairs (QARA) professionals in market access is explored.Walmart's ad unit has experienced significant growth, with ad sales from marketplace sellers increasing by nearly 50% in fiscal Q2. The digital economy is expected to expand, particularly in online retail and online travel. Marketers are increasingly turning to first-party data strategies and behavioral data to enhance their marketing efforts. Industry Dive provides insights and news for marketing leaders, covering topics such as brand strategy, social media, video marketing, and more. Companies can post press releases on Marketing Dive to share announcements with a wide audience.
…
continue reading
78 episodes